Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Analysis of PARP inhibitor toxicity by multidimensional fluorescence microscopy reveals mechanisms of sensitivity and resistance
Jone Michelena, Aleksandra Lezaja, Federico Teloni, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 109

Showing 1-25 of 109 citing articles:

PARP and PARG inhibitors in cancer treatment
Dea Slade
Genes & Development (2020) Vol. 34, Iss. 5-6, pp. 360-394
Open Access | Times Cited: 525
PARP Inhibitors: Clinical Relevance, Mechanisms of Action and Tumor Resistance
Maddison Rose, Joshua T. Burgess, Kenneth J. O’Byrne, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 515
Phase separation of 53 BP 1 determines liquid‐like behavior of DNA repair compartments
Sinan Kilic, Aleksandra Lezaja, Marco Gatti, et al.
The EMBO Journal (2019) Vol. 38, Iss. 16
Open Access | Times Cited: 371
Understanding and overcoming resistance to PARP inhibitors in cancer therapy
Mariana Paes Dias, Sarah C. Moser, Shridar Ganesan, et al.
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 12, pp. 773-791
Closed Access | Times Cited: 359
The antitumorigenic roles of BRCA1–BARD1 in DNA repair and replication
Madalena Tarsounas, Patrick Sung
Nature Reviews Molecular Cell Biology (2020) Vol. 21, Iss. 5, pp. 284-299
Open Access | Times Cited: 277
Replication gaps are a key determinant of PARP inhibitor synthetic lethality with BRCA deficiency
Ke Cong, Min Peng, Arne Nedergaard Kousholt, et al.
Molecular Cell (2021) Vol. 81, Iss. 15, pp. 3128-3144.e7
Open Access | Times Cited: 241
A RAD 51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation
Marta Castroviejo‐Bermejo, Cristina Cruz, Alba Llop‐Guevara, et al.
EMBO Molecular Medicine (2018) Vol. 10, Iss. 12
Open Access | Times Cited: 222
ALC1 links chromatin accessibility to PARP inhibitor response in homologous recombination-deficient cells
Priyanka Verma, Yeqiao Zhou, Zhendong Cao, et al.
Nature Cell Biology (2021) Vol. 23, Iss. 2, pp. 160-171
Open Access | Times Cited: 122
The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin
Dragomir B. Krastev, Shudong Li, Yilun Sun, et al.
Nature Cell Biology (2022) Vol. 24, Iss. 1, pp. 62-73
Open Access | Times Cited: 112
Preclinical Characterization of AZD5305, A Next-Generation, Highly Selective PARP1 Inhibitor and Trapper
Giuditta Illuzzi, Anna D. Staniszewska, Sonja J. Gill, et al.
Clinical Cancer Research (2022) Vol. 28, Iss. 21, pp. 4724-4736
Open Access | Times Cited: 96
Leveraging the replication stress response to optimize cancer therapy
Emily Cybulla, Alessandro Vindigni
Nature reviews. Cancer (2022) Vol. 23, Iss. 1, pp. 6-24
Open Access | Times Cited: 70
A comparative pharmacokinetic study of PARP inhibitors demonstrates favorable properties for niraparib efficacy in preclinical tumor models
Kaiming Sun, Keith Mikule, Zebin Wang, et al.
Oncotarget (2018) Vol. 9, Iss. 98, pp. 37080-37096
Open Access | Times Cited: 136
The Role of PARPs in Inflammation—And Metabolic—Related Diseases: Molecular Mechanisms and Beyond
Yueshuang Ke, Chenxin Wang, Jiaqi Zhang, et al.
Cells (2019) Vol. 8, Iss. 9, pp. 1047-1047
Open Access | Times Cited: 100
The Ubiquitin Ligase TRIP12 Limits PARP1 Trapping and Constrains PARP Inhibitor Efficiency
Marco Gatti, Ralph Imhof, Qingyao Huang, et al.
Cell Reports (2020) Vol. 32, Iss. 5, pp. 107985-107985
Open Access | Times Cited: 95
Targeting therapeutic vulnerabilities with PARP inhibition and radiation in IDH-mutant gliomas and cholangiocarcinomas
Yuxiang Wang, Aaron T. Wild, Şevin Turcan, et al.
Science Advances (2020) Vol. 6, Iss. 17
Open Access | Times Cited: 87
The Oncogenic Helicase ALC1 Regulates PARP Inhibitor Potency by Trapping PARP2 at DNA Breaks
Charlotte Blessing, Imke K. Mandemaker, Claudia Gonzalez-Leal, et al.
Molecular Cell (2020) Vol. 80, Iss. 5, pp. 862-875.e6
Open Access | Times Cited: 87
Efficient Pre-mRNA Cleavage Prevents Replication-Stress-Associated Genome Instability
Federico Teloni, Jone Michelena, Aleksandra Lezaja, et al.
Molecular Cell (2019) Vol. 73, Iss. 4, pp. 670-683.e12
Open Access | Times Cited: 81
The trans cell cycle effects of PARP inhibitors underlie their selectivity toward BRCA1/2-deficient cells
Antoine Simoneau, Rosalinda Xiong, Lee Zou
Genes & Development (2021) Vol. 35, Iss. 17-18, pp. 1271-1289
Open Access | Times Cited: 81
Premature mitotic entry induced by ATR inhibition potentiates olaparib inhibition‐mediated genomic instability, inflammatory signaling, and cytotoxicity in BRCA2‐deficient cancer cells
Pepijn M. Schoonen, Yannick P. Kok, Elles Wierenga, et al.
Molecular Oncology (2019) Vol. 13, Iss. 11, pp. 2422-2440
Open Access | Times Cited: 77
Sequential role of RAD51 paralog complexes in replication fork remodeling and restart
Matteo Berti, Federico Teloni, Sofija Mijic, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 76
Combined inhibition of Aurora-A and ATR kinases results in regression of MYCN-amplified neuroblastoma
Isabelle Roeschert, Evon Poon, Anton G. Henssen, et al.
Nature Cancer (2021) Vol. 2, Iss. 3, pp. 312-326
Open Access | Times Cited: 76
Serine-linked PARP1 auto-modification controls PARP inhibitor response
Evgeniia Prokhorova, Florian Zobel, Rebecca Smith, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 76
PARP1 proximity proteomics reveals interaction partners at stressed replication forks
Thorsten Mosler, H. Irem Baymaz, Justus F. Gräf, et al.
Nucleic Acids Research (2022) Vol. 50, Iss. 20, pp. 11600-11618
Open Access | Times Cited: 41
Loss of the receptors ER, PR and HER2 promotes USP15-dependent stabilization of PARP1 in triple-negative breast cancer
Xiaoxiang Sun, Huanyin Tang, Yu Chen, et al.
Nature Cancer (2023) Vol. 4, Iss. 5, pp. 716-733
Closed Access | Times Cited: 29
ADP-ribose contributions to genome stability and PARP enzyme trapping on sites of DNA damage; paradigm shifts for a coming-of-age modification
Élise Rouleau-Turcotte, John M. Pascal
Journal of Biological Chemistry (2023) Vol. 299, Iss. 12, pp. 105397-105397
Open Access | Times Cited: 25
Page 1 - Next Page

Scroll to top